References
- Baum J. K., Holtz F., Bookstein J. J., Klein E. W. Possible association between benign hepatomas and oral contraceptives. Lancet, 1973, 2: 926–929.
- Benhamou J. P. Oral contraceptives and benign tumours of the liver. Gastro-enterol Clin Biol, 1997, 21 (12): 913–915.
- Tao L. C. Oral contraceptive associated liver cell adenoma and hepatocellular carcinoma. Cancer, 1991, 68: 341–347.
- La Vecchia C., Negri E., Franceschi S., D’Avanzo B. Reproductive factors and the risk of hepatocellular carcinoma in women. Int J Cancer, 1992, 52: 351–354.
- Boyd P., Mark G. Multiple hepatic adenomas and a hepatocellu-lar carcinoma in a man on oral methyltestosterone for eleven years. Cancer, 1977, 40: 1765–1770.
- Nagasue N., Ito A., Yukaya H., Ogawa Y. Estrogen receptors in hepatocellular carcinoma. Cancer, 1986, 57: 87–91.
- Kai S. Nine-year follow-up of a case of benign liver cell adenoma related to oral contraceptives. Cancer, 1977, 40: 1759–1760.
- Mishkin S. Y., Farber E., Ho K. H., Mulay S., Mishkin S. Evidence of the hormone dependency of hepatic hyperplastic nodules: inhibition of malignant transformation after exogenous 17-estradiol and tamoxifen. Hepatology, 1983, 3: 308–316.
- Mansvelt B., Bertrand C., Versaille H., Nokermann P., Etienne P., de Neve de Roden A. Systematic use of total vascular exclusion in 14 elective hepatic resections. Acta Chir Belg, 1999, 99: 159–162.
- Galifer R. B., Sultan C., Margueritte G., Barneon G. Testosterone-producing hepatoblastoma in a 3-year-old boy with precocious puberty. J Pediatr Surg, 1985 Dec, 20 (6): 713–4.